Global Superdisintegrants Market Analysis 2014-2017 & 2025 - Research and Markets

DUBLIN--()--The "Superdisintegrants Market Analysis by Product (Croscarmellose sodium, Crospovidone, Sodium starch glycolate, Ion exchange resin), by Dosage Form (Tablets and Capsules, Mouth-dissolving Films) and Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

The global superdisintegrants market is expected to reach USD 487.0 million by 2025

Superdisintegrants help in the disintegration of tablet or capsule content into small particles and create a greater surface area for speedy drug release.

A number of fast disintegrating tablet such as salbutamol sulphate, and cetirizine hydrochloride in tablet/capsule dosage form for respiratory disorders (bronchitis, asthma, and coughing) are formulated for pediatric and geriatric patients, due to their difficulty or discomfort in swallowing. Superdisintegrant such as crospovidone, croscarmellose sodium, and sodium starch glycolate are used in optimized concentration to formulate such tablets/capsules along with different binders such as MCC and PVP K-30.

Some of the major companies operating in this market are Ashland Global Holdings Inc., Roquette Frres S.A., FMC Corporation, DFE Pharma, Huber Corporation, Nippon Soda Co., Ltd. The Dow Chemical Company and BASF SE. and others.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Superdisintegrants Market Variables, Trends & Scope

Chapter 4 Superdisintegrants Market: Product Estimates & Trend Analysis

Chapter 5 Superdisintegrants Market: Dosage Form Estimates & Trend Analysis

Chapter 6 Superdisintegrants Market: Regional Estimates & Trend Analysis, by Product & Dosage Form

Chapter 7 Competitive Landscape

  • Ashland Global Holdings Inc.
  • BASF SE
  • Company Profiles
  • DFE Pharma
  • FMC Corporation
  • Huber Corporation
  • Nippon Soda Co., Ltd.
  • Roquette Frres S.A.
  • Strategy Framework
  • The Dow Chemical Company

For more information about this report visit https://www.researchandmarkets.com/research/sk3s22/superdisintegrants

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Intermediates

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Intermediates